Navigation Links
Satyam Forms Partnership with Sciformix to Provide Comprehensive Drug Safety Management
Date:6/26/2008

Alliance empowers life sciences clients to take a more proactive approach

to collection and assessment of drug safety information

HYDERABAD, India and WESTBOROUGH, Mass., June 26 /PRNewswire-FirstCall/ -- Satyam Computer Services Ltd. (NYSE: SAY), a leading global consulting and information technology services provider, announced today that it has formed an alliance with Sciformix Corporation, a Westborough, Mass.-based, Life Science Knowledge Process Outsourcing (KPO) company, to deliver end-to-end data management services in "Pharmacovigilance."

The partnership addresses the worldwide increase in focus on drug safety, which is leading to increased volumes of adverse events being reported to the regulatory authorities. Satyam and Sciformix will collaborate to enable pharmaceutical and biotechnology companies to better monitor the safety of the products they market by offering services across the safety management spectrum, ranging from case intake to international regulatory reporting. The alliance also enables the organizations to offer these services in a way that is both cost-efficient and scalable, via a proven global delivery model.

Additionally, the alliance leverages Sciformix's in-depth understanding of the pharmaceutical and life sciences domain with Satyam's proven drug safety Business Process Outsourcing (BPO) capabilities. It will provide services to a wide range of clients in the pharmaceutical, biotechnology and life sciences industries.

"We are very pleased by this partnership. Sciformix has deep expertise delivering end-to-end safety management services, from adverse event intake to regulatory submissions," said Kishore Rachapudi, Satyam's global head of life sciences. "We will leverage our extensive experience managing large-scale IT and BPO solutions and work with Sciformix to offer a scalable platform for delivery of drug safety services. At the same time, we reaffirm our commitment to providing the widest range of services through the most advanced global delivery models available."

Several high-profile withdrawals of popular drugs from the marketplace have also made this partnership more important. The withdrawals have pharmaceutical companies looking for ways to manage risk and taking a more proactive approach toward collection and assessment of drug safety information.

"These are some of the most important reasons we have formed this partnership," said Dinesh Thakur, president and Chief Executive Officer of Sciformix, "Satyam brings years of experience delivering outsourced services to global customers. Its large-scale global delivery services capacity and experience in the life sciences industry, along with Sciformix's deep domain expertise, offer global pharmaceutical, biotechnology and life sciences companies a unique alliance for delivery of high-quality services."

About Satyam

Satyam (NYSE: SAY), a leading global business and information technology services company, delivers consulting, systems integration, and outsourcing solutions to clients in 20* industries and 63* countries.

Satyam leverages deep industry and functional expertise, leading technology practices, and an advanced, global delivery model to help clients transform their highest-value business processes and improve their business performance. The company's 51,127* professionals excel in engineering and product development, supply chain management, client relationship management, business process quality, business intelligence, enterprise integration, and infrastructure management, among other key capabilities.

Satyam development and delivery centers in the US, Canada, Brazil, the UK, Hungary, Egypt, UAE, India, China, Malaysia, Singapore, and Australia serve 654* clients, including more than one third of the Fortune 500. For more information, see http://www.satyam.com.

*As of March 31, 2008

About Sciformix Corporation

Founded in the U.S. with headquarters in Westborough, MA, and a Pharmacovigilance Center of Excellence in Mumbai, India, Sciformix is a fast growing knowledge process outsourcing (KPO) company providing drug safety data management, clinical data management, biostatistics & programming and medical writing services to pharmaceutical, biotechnology and life science companies globally. Sciformix has an experienced leadership team driving its rapid growth and expansion. For more information on Sciformix, please visit http://www.sciformix.com.

Contacts:

Satyam Computers Limited Sciformix Corporation

Rajiv Prasad, AVP Life Sciences Jeffrey S. Yablon, Vice President,

Rajiv_Prasad@satyambpo.com Sales & Marketing

jeffrey.yablon@sciformix.com

Satyam Contacts

For clarifications, write to us at MediaRelations@Satyam.com

Or contact our global PR representatives at:

India Meigha Humbre, meigha_humbre@satyam.com

+91-970-360-8822

Rachna Pandey, Rachna_pandey@satyam.com

+91-970-303-8743

US Jim Swords, james_swords@satyam.com

+1-703-877-2225

Europe Sandeep Thawani, sandeep_thawani@satyam.com

+44-20-7309-1037

Asia-Pacific Dan Bleakman, Dan@howorth.com.au

+61-439-408-484

Reshma Wad Jain, Reshma@wer1.net

+65-98-140-507

Safe Harbor

This press release contains forward-looking statements within the meaning of section 27A of Securities Act of 1933, as amended, and section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements contained herein are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward- looking statements. Satyam undertakes no duty to update any forward-looking statements. For a discussion of the risks associated with our business, please see the discussions under the heading "Risk Factors" in our report on Form 6-K concerning the quarter ended December 31, 2007, furnished to the United States Securities Exchange Commission on January 28, 2008 and the other reports filed with the Securities Exchange Commission from time to time. These filings are available at http://www.sec.gov.

This announcement is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States absent registration or an exemption from registration. Any public offering of securities to be made in the United States will be made by means of a prospectus that may be obtained from Satyam and that will contain detailed information about Satyam and its management, as well as financial statements.


'/>"/>
SOURCE Satyam Computer Services Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Forms Mexican Subsidiary
2. BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts
3. American Oriental Bioengineering Forms Science and Technology Advisory Committee
4. IC Sciences Announces Launch of ICS Advisory Services Intellectual Property Platforms Available Through ICSciences Alliance
5. Agrenco Informs Sale of Biodiesel at ANP Auction
6. Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines
7. International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) Initiative
8. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
9. febit Forms Scientific Advisory Board
10. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
11. Technology Transforms Market Research in Pharmaceutical Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... -- Windtree Therapeutics, Inc. (Nasdaq: WINT ), ... therapies for respiratory diseases, will host a conference call ... EST on Thursday, February 16, 2017 to provide updates ... announced closing of a $10.5 million private offering and ... in the live call and take part in the ...
Breaking Biology Technology:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):